EVs-mediated delivery of CB2 receptor agonist for Alzheimer's disease therapy

EVs-mediated delivery of CB2 receptor agonist for Alzheimer's disease therapy

Alzheimer's disease (AD) is a typical neurodegenerative disease that leads to irreversible neuronal degeneration, and effective treatment remains elusive due to the unclear mechanism. We utilized biocompatible mesenchymal stem cell-derived extracellular vesicles as carriers loaded with the CB2...

Full description

Bibliographic Details
Main Authors: Yanjing Zhu, Ruiqi Huang, Deheng Wang, Liqun Yu, Yuchen Liu, Runzhi Huang, Shuai Yin, Xiaolie He, Bairu Chen, Zhibo Liu, Liming Cheng, Rongrong Zhu
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Asian Journal of Pharmaceutical Sciences
Subjects:
Extracellular vesicles
Alzheimer's disease
CB2 receptor agonist
Neurodegenerative disorders
Neuronal regeneration
Online Access:http://www.sciencedirect.com/science/article/pii/S1818087623000624

Internet

http://www.sciencedirect.com/science/article/pii/S1818087623000624

Similar Items